Edwin Tan Synopsis Rockwell Medical (NASDAQ:RMTI) is a microcap manufacturer and distributor of hemodialysis concentrates that are critical in the life-saving dialysis treatments over half a million Americans receive due to kidney failure. The company currently trades for well under 1x full-year 2023 revenue, despite a sustained trend towards profitability due to increased gross margins under relatively new management. In this article, I cover what I view as the company’s current market opportunity, wha ...